176 related articles for article (PubMed ID: 31776158)
1. Proteinase 3 (PR3)-antineutrophil cytoplasmic antibody (ANCA)-associated vasculitic neuropathy in diffuse cutaneous systemic sclerosis: a rare duo.
Radwan Y; Berini S; Ernste F; Makol A
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31776158
[TBL] [Abstract][Full Text] [Related]
2. Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.
Derrett-Smith EC; Nihtyanova SI; Harvey J; Salama AD; Denton CP
Rheumatology (Oxford); 2013 Oct; 52(10):1824-31. PubMed ID: 23832959
[TBL] [Abstract][Full Text] [Related]
3. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis.
Moxey J; Huq M; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Ross L; Major G; Roddy J; Stevens W; Nikpour M
Arthritis Res Ther; 2019 Feb; 21(1):57. PubMed ID: 30764870
[TBL] [Abstract][Full Text] [Related]
4. ANCA-associated vasculitis in scleroderma: A renal perspective
.
Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
[TBL] [Abstract][Full Text] [Related]
5. Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab.
Yoshida S; Hanai S; Nakagomi D; Kobayashi K; Takahashi K; Furuya F
Intern Med; 2021 Jan; 60(1):145-150. PubMed ID: 32830174
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
McAdoo SP; Hall A; Levy J; Salama AD; Pusey CD
J Clin Rheumatol; 2012 Oct; 18(7):336-40. PubMed ID: 23047533
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
9. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO
Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673
[TBL] [Abstract][Full Text] [Related]
10. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review.
Bele D; Kojc N; Perše M; Černe Čerček A; Lindič J; Aleš Rigler A; Večerić-Haler Ž
BMC Nephrol; 2020 Jan; 21(1):40. PubMed ID: 32005179
[TBL] [Abstract][Full Text] [Related]
14. Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
Nakabayashi K; Fujioka Y; Arimura Y; Fukuoka T; Marumo T; Umino M; Kamiya Y; Okai T; Tsurumaki S; Nagasawa T; Yamada A
Clin Exp Nephrol; 2011 Aug; 15(4):504-13. PubMed ID: 21476125
[TBL] [Abstract][Full Text] [Related]
15. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
17. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
Hilhorst M; van Paassen P; Tervaert JW;
J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review.
Wu R; Su J; Zou YR; Zhu J
Eur J Med Res; 2021 Mar; 26(1):30. PubMed ID: 33789719
[TBL] [Abstract][Full Text] [Related]
20. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
Fussner LA; Hummel AM; Schroeder DR; Silva F; Cartin-Ceba R; Snyder MR; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; William St Clair E; Tchao NK; Stone JH; Specks U;
Arthritis Rheumatol; 2016 Jul; 68(7):1700-10. PubMed ID: 26882078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
